Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Apply
Obinutuzumab & ICE
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step